SCHEMBL30498697

SCHEMBL30498697

Oc1ccccc1-c1cnnc(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.45
HSD17B10 Q99714 2/20 0.45
ALDH1A1 P00352 1/20 0.45
BCL2L1 Q07817 1/20 0.45
KMT2A Q03164 5/20 0.42
ESR2 Q92731 1/20 0.40
SMARCA2 P51531 2/20 0.39
SMARCA4 P51532 2/20 0.39
BRD4 O60885 1/20 0.39
NR1I2 O75469 1/20 0.39
PBRM1 Q86U86 1/20 0.39
MEN1 O00255 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 2/20 0.37
ALOX15 P16050 2/20 0.37
NFKB1 P19838 2/20 0.37
NFKB2 Q00653 2/20 0.37
RELA Q04206 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21066163 0.81 GABRG2 (0.46) HPGDALDH1A1KMT2ASMARCA2SMARCA4
SCHEMBL10535514 0.81 CYP2A6 (0.48) HPGDHSD17B10ALDH1A1NPC1RAB9A
SCHEMBL5114621 0.75 GABRG2 (0.61) HPGDALDH1A1KMT2AMEN1NPC1
SCHEMBL30072473 0.75 GABRG2 (0.61) HPGDALDH1A1KMT2AMEN1NPC1
SCHEMBL5918300 0.75 PDGFRB (0.50) HPGDALDH1A1SMN1; SMN2LMNA
SCHEMBL3626709 0.73 RORB (0.49) HPGDHSD17B10ALDH1A1BCL2L1KMT2A
SCHEMBL27779502 0.73 HPGD (0.47) HPGDHSD17B10ALDH1A1BCL2L1KMT2A
SCHEMBL29499205 0.72 HPGD (0.56) HPGDHSD17B10ALDH1A1BCL2L1KMT2A
SCHEMBL25220858 0.72 ESR1 (0.44) BCL2L1KMT2AESR2MEN1NPC1
SCHEMBL27586879 0.72 ALDH1A1 (0.50) HPGDHSD17B10ALDH1A1BCL2L1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116529250-A 6-substituted pyridazine compounds as SMARCA2 and/or SMARCA4 degrading agents 奥里吉恩肿瘤学有限公司 2023-08-01 CN disclosed